A “format” is how a dose is delivered — whole dried material, a capsule, a tincture, an edible. Changing the format can change two things: how consistent the dose is from one time to the next, and the drug’s pharmacokinetics — how fast and how completely it is absorbed. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 It cannot change whether a sub-perceptual effect exists. The placebo-controlled evidence has not established that effect in the first place, [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 so no choice of container can make an undemonstrated effect real. This cluster examines format claims as claims, and reproduces none of the buying-guide or recipe framing found elsewhere. [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
Education-only orientation. This is not medical, dosing, sourcing, preparation, or legal advice. Decisions about any substance belong with a qualified clinician.
What this page does and does not contain. It examines formats as a pharmacology and measurement topic and does not recommend, rank, or instruct on any format. It contains no preparation recipes or steps, no doses, weights, ratios, milligrams, gram amounts, scales, or increments, no format-sequencing-by-cycle, no product, brand, or store recommendations, no “best format” verdict, and no potency- or onset-boosting claim stated as fact. Every such claim from buying guides is examined here as a claim, not reproduced as instruction.
What “format” means here
In everyday microdosing talk, “format” is shorthand for a purchase decision: whole mushrooms, capsules, gummies, a stack. In pharmacology the precise term is dosage form — the physical configuration in which an active compound is presented. A dosage form determines the route and the conditions of absorption. It does not determine whether the compound produces a benefit at a given dose. Those are separate questions, and conflating them is the central error this cluster exists to correct.
The thesis: a format is a delivery mechanism, not evidence
Format claims almost always answer the wrong question. “Which format works best?” presupposes that a format works — that there is a measurable microdose effect whose size or reliability one container improves over another. The evidence does not support that premise. Across controlled and self-blinded studies, much of what people attribute to microdosing is consistent with expectation rather than a drug effect. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 A format can make a dose easier to measure and can shift its timing, but neither of those is a demonstrated outcome.
This is the direct sequel to the Optimization cluster’s thesis. There, the point was that you cannot optimize an effect not yet demonstrated. Here it is narrower and more basic: a format governs whether you can even measure a consistent dose — a precondition for studying anything, not a result.
The four distinctions, applied to formats
| Distinction | A format claim that violates it | The honest reading |
|---|---|---|
| mechanism ≠ result | ”Conversion to the active form makes it stronger” | A metabolic step is a mechanism, not a measured microdose outcome |
| full-dose ≠ microdose | ”Faster onset, more intense” | Onset and intensity reports come from full-dose anecdote and do not transfer to sub-perceptual use |
| reports ≠ outcomes | ”Most experienced users prefer capsules” | A preference survey is a report, not evidence of effect |
| plausibility ≠ efficacy | ”Tinctures absorb better, so they work better” | Better absorption is plausible pharmacokinetics, not demonstrated benefit |
What a format can and cannot do
| A format CAN affect | A format CANNOT do |
|---|---|
| Dose consistency from one use to the next | Create an effect that has not been demonstrated |
| Pharmacokinetics: rate and extent of absorption | Validate a benefit a controlled study has not shown |
| Convenience, palatability, shelf stability | Convert a self-report into a controlled outcome |
| Whether a dose can be measured for study | Make a microdose “work better” in any demonstrated sense |
A format that improves measurement is genuinely useful to research — an inconsistent dose makes any evaluation unreadable. But that usefulness is about study quality, not about a personal result. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
How this cluster routes everywhere else
Formats touch many topics but own none of them. What a microdose even is belongs to Foundations. Why potency varies batch to batch sits in Mushroom Intelligence. The conversion of psilocybin to its active form is detailed in How It Works. Dose-finding as a research concept is in Optimization; the Stamets Stack is examined there as a claim, not pitched here as a product. Risk lives in Safety and legality in Legal Status. This page is the map; the articles that follow are the territory.
- Delivery, not evidence
- A format changes how a dose is delivered, not whether it works. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- Consistency is a precondition
- A measurable, repeatable dose is required before any effect can be studied — it is not itself a result. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
- No baseline to improve
- The placebo-controlled evidence has not established a microdose effect for a format to enhance. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831
- Claims, not recipes
- Every format topic here is examined as a claim; no preparation, dose, or product is reproduced. [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
Frequently asked questions
Does this cluster tell me which format is best?
No. “Which format is best” presupposes that a format produces a measurable benefit one container improves over another, and that base effect has not been demonstrated beyond placebo. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 The cluster examines format claims as claims. It names no best format and recommends no product.
What can a format actually change?
Two things: dose consistency, meaning how repeatable the amount is from one use to the next, and pharmacokinetics, meaning how fast and how completely the compound is absorbed. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Both are real and both matter for whether a dose can be studied. Neither is evidence that an effect exists or that one format produces a better result.
How is this different from the version on the .net site?
The mirror page is a buying-and-preparation guide: it compares products, gives weights and scale increments, sequences formats by cycle, attaches store links, and frames lab-tested capsules as producing better results. [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 This site reproduces none of that. It treats each of those as a claim to examine against the evidence, not a step to follow.
Where do dosing, potency, and the Stamets Stack belong?
Each lives in another cluster and is referenced, not duplicated, here. What a microdose is sits in Foundations; why potency varies sits in Mushroom Intelligence; dose-finding as a research concept and the Stamets Stack as a claim sit in Optimization. This cluster only addresses what formats do and do not change.